当前位置: X-MOL 学术J. Am. Coll. Cardiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cardiovascular Complications of Cancer Therapy
Journal of the American College of Cardiology ( IF 24.0 ) Pub Date : 2017-11-01 , DOI: 10.1016/j.jacc.2017.09.1096
Hui-Ming Chang , Rohit Moudgil , Tiziano Scarabelli , Tochukwu M. Okwuosa , Edward T.H. Yeh

Modern cancer therapy has successfully cured many cancers and converted a terminal illness into a chronic disease. Because cancer patients often have coexisting heart diseases, expert advice from cardiologists will improve clinical outcome. In addition, cancer therapy can also cause myocardial damage, induce endothelial dysfunction, and alter cardiac conduction. Thus, it is important for practicing cardiologists to be knowledgeable about the diagnosis, prevention, and management of the cardiovascular complications of cancer therapy. In this first part of a 2-part review, we will review cancer therapy-induced cardiomyopathy and ischemia. This review is based on a MEDLINE search of published data, published clinical guidelines, and best practices in major cancer centers. With the number of cancer survivors expanding quickly, the time has come for cardiologists to work closely with cancer specialists to prevent and treat cancer therapy-induced cardiovascular complications.

中文翻译:

癌症治疗的心血管并发症

现代癌症疗法已经成功治愈了许多癌症,并将绝症转化为慢性病。由于癌症患者通常合并有心脏病,心脏病专家的专家建议将改善临床结果。此外,癌症治疗还会引起心肌损伤,诱发内皮功能障碍,改变心脏传导。因此,对于执业心脏病专家来说,了解癌症治疗心血管并发症的诊断、预防和管理是很重要的。在两部分综述的第一部分中,我们将回顾癌症治疗引起的心肌病和缺血。本综述基于 MEDLINE 对已发表数据、已发表临床指南和主要癌症中心的最佳实践的搜索。随着癌症幸存者的数量迅速增加,
更新日期:2017-11-01
down
wechat
bug